litlas
Log inCreate account

Edi Brogi

Active 1992–2025

119
Papers
23,830
Citations
70
h-index
113
i10-index

Citations

Citations per year for Edi Brogi1974: 1 citations1989: 1 citations1992: 1 citations1993: 5 citations1994: 11 citations1995: 43 citations1996: 72 citations1997: 94 citations1998: 113 citations1999: 103 citations2000: 96 citations2001: 80 citations2002: 64 citations2003: 53 citations2004: 55 citations2005: 38 citations2006: 39 citations2007: 47 citations2008: 54 citations2009: 39 citations2010: 60 citations2011: 75 citations2012: 110 citations2013: 163 citations2014: 154 citations2015: 220 citations2016: 237 citations2017: 265 citations2018: 252 citations2019: 865 citations2020: 1,114 citations2021: 1,345 citations2022: 1,055 citations2023: 945 citations2024: 1,138 citations2025: 632 citations2026: 103 citations1975–1988: no citations, so these years are not shown1990–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,648 citing papers, 26.7% of this breakdownChina: 1,902 citing papers, 13.9% of this breakdownUnited Kingdom: 787 citing papers, 5.8% of this breakdownItaly: 661 citing papers, 4.8% of this breakdownGermany: 648 citing papers, 4.7% of this breakdownFrance: 418 citing papers, 3.1% of this breakdownSpain: 383 citing papers, 2.8% of this breakdownJapan: 383 citing papers, 2.8% of this breakdownAustralia: 366 citing papers, 2.7% of this breakdownCanada: 363 citing papers, 2.7% of this breakdownSwitzerland: 333 citing papers, 2.4% of this breakdownNetherlands: 299 citing papers, 2.2% of this breakdown
0%26.7%Other 25.4%

Institutions

Fields

  • Medicine41.8%
  • Biochemistry, Genetics and Molecular Biology34.7%
  • Computer Science15.2%
  • Immunology and Microbiology4.9%
  • Engineering1.1%
  • Neuroscience0.8%
  • Other1.5%

Topics

  • AI in cancer detection6%
  • Cancer Cells and Metastasis4.2%
  • Radiomics and Machine Learning in Medical Imaging3.4%
  • Breast Cancer Treatment Studies2.9%
  • Cancer Genomics and Diagnostics2.5%
  • Angiogenesis and VEGF in Cancer2.5%
  • Other78.5%

Coauthors

All papers

Open in search
  1. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images

    Authors: Gabriele Campanella, Matthew G. Hanna, Luke Geneslaw, Allen P. Miraflor, Vitor Werneck Krauss Silva, Klaus J. Busam, Edi Brogi, Victor E. Reuter, David S. Klimstra, Thomas J. Fuchs - Nature Medicine 2019 cited by 2,619

  2. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    Authors: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 cited by 1,006

  3. The 2019 World Health Organization classification of tumours of the breast

    Authors: Puay Hoon Tan, Ian O. Ellis, Kimberly H. Allison, Edi Brogi, Stephen B. Fox, Sunil R. Lakhani, Alexander J. Lazar, Elizabeth A. Morris, Ayşegül A. Şahin, Roberto Salgado, Anna Sapino, Hironobu Sasano, Stuart J. Schnitt, Christos Sotiriou, Paul van Diest, Valerie A. White, Dilani Lokuhetty, Ian A. Cree, for the WHO Classification of Tumours Editorial Board - Histopathology 2020 cited by 1,074

  4. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    Authors: Zhiqiang Li, Pedram Razavi, Qing Li, Weiyi Toy, Bo Liu, Christina Ping, Wilson C. Hsieh, Francisco Sánchez-Vega, David N. Brown, Arnaud Da Cruz Paula, Luc G.T. Morris, Pier Selenica, Emily M. Eichenberger, Ronglai Shen, Nikolaus Schultz, Neal Rosen, Maurizio Scaltriti, Edi Brogi, José Baselga, Jorge S. Reis‐Filho, Sarat Chandarlapaty - Cancer Cell 2018 cited by 521

  5. A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

    Authors: Swarnali Acharyya, Thórdur Óskarsson, Sakari Vanharanta, Srinivas Malladi, Juliet Kim, Patrick G. Morris, Katia Manova‐Todorova, Margaret Leversha, Nancy Hogg, Venkatraman Seshan, Larry Norton, Edi Brogi, Joan Massagué - Cell 2012 cited by 1,125

  6. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis

    Authors: Manuel Valiente, Anna C. Obenauf, Xin Jin, Qing Chen, Xiang H.-F. Zhang, Derek J. Lee, Jamie E. Chaft, Mark G. Kris, Jason T. Huse, Edi Brogi, Joan Massagué - Cell 2014 cited by 896

  7. Tumor Heterogeneity in Breast Cancer

    Authors: Gulisa Turashvili, Edi Brogi - Frontiers in Medicine 2017 cited by 563

  8. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization

    Authors: Ekrem Emrah Er, Manuel Valiente, Karuna Ganesh, Yilong Zou, Saloni Agrawal, Jing Hu, Bailey Griscom, Marc K. Rosenblum, Adrienne Boire, Edi Brogi, Filippo G. Giancotti, Melitta Schachner, Srinivas Malladi, Joan Massagué - Nature Cell Biology 2018 cited by 286

  9. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss

    Authors: Gayatri Arun, Sarah D. Diermeier, Martin Akerman, Kung-Chi Chang, John E. Wilkinson, Stephen Hearn, Youngsoo Kim, A. Robert MacLeod, Adrian R. Krainer, Larry Norton, Edi Brogi, Mikala Egeblad, David L. Spector - Genes & Development 2015 cited by 570

  10. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs

    Authors: Thórdur Óskarsson, Swarnali Acharyya, Xiang H.-F. Zhang, Sakari Vanharanta, Sohail F. Tavazoie, Patrick G. Morris, Robert J. Downey, Katia Manova‐Todorova, Edi Brogi, Joan Massagué - Nature Medicine 2011 cited by 857

  11. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Authors: Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen, Koen Van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil Badve, W. Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle Loibl, Stephen J. Luen, John M. S. Bartlett, Peter Savas, Giancarlo Pruneri, Deborah Dillon, Maggie C.U. Cheang, Andrew Tutt, Jacqueline A. Hall, Marleen Kok, Hugo M. Horlings, Anant Madabhushi, Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo and 156 more - npj Breast Cancer 2020 cited by 206

  12. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S

    Authors: Lisa Sevenich, Robert L. Bowman, Steven D. Mason, Daniela F. Quail, Franck Rapaport, Benelita T. Elie, Edi Brogi, Priscilla K. Brastianos, William C. Hahn, Leslie J. Holsinger, Joan Massagué, Christina S. Leslie, Johanna A. Joyce - Nature Cell Biology 2014 cited by 377

  13. Deep Multi-Magnification Networks for Multi-Class Breast Cancer Image Segmentation

    Authors: David Joon Ho, Dig Vijay Kumar Yarlagadda, Timothy M. D'Alfonso, Matthew G. Hanna, Anne Grabenstetter, Peter Ntiamoah, Edi Brogi, Lee K. Tan, Thomas J. Fuchs - Computerized Medical Imaging and Graphics, Comput. Medical Imaging Graph. 2021 cited by 114

  14. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

    Authors: Tanaya Shree, Oakley C. Olson, Benelita T. Elie, Jemila C. Kester, Alfred L. Garfall, Kenishana Simpson, Katherine M. Bell‐McGuinn, Emily C. Zabor, Edi Brogi, Johanna A. Joyce - Genes & Development 2011 cited by 532

  15. Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling

    Authors: Hua Gao, Goutam Chakraborty, Zhanguo Zhang, Intissar Akalay, Mayur Gadiya, Yaquan Gao, Surajit Sinha, Jian Hu, Cizhong Jiang, Muzaffar Akram, Edi Brogi, Birgit Leitinger, Filippo G. Giancotti - Cell 2016 cited by 251

  16. The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites

    Authors: Hua Gao, Goutam Chakraborty, Ai Ping Lee-Lim, Qianxing Mo, Markus Decker, Alin Vonica, Ronglai Shen, Edi Brogi, Ali H. Brivanlou, Filippo G. Giancotti - Cell 2012 cited by 449

  17. Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma

    Authors: Xiang H.-F. Zhang, Xin Jin, Srinivas Malladi, Yilong Zou, Yong Wen, Edi Brogi, Marcel Smid, John A. Foekens, Joan Massagué - Cell 2013 cited by 425

  18. A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling

    Authors: Heather L. McArthur, Adi Diab, David B. Page, Jianda Yuan, Stephen B. Solomon, Virgilio Sacchini, Christopher Comstock, Jeremy C. Durack, Majid Maybody, Janice S. Sung, Arielle A. Ginsberg, Phillip Wong, Afşar Barlas, Zhiwan Dong, Chunjun Zhao, Brian Blum, Sujata Patil, Deirdre Neville, Elizabeth Comen, Elizabeth A. Morris, Alan Kotin, Edi Brogi, Yuetao Wen, Monica Morrow, Mario E. Lacouture, Padmanee Sharma, James P. Allison, Clifford A. Hudis, Jedd D. Wolchok, Larry Norton - Clinical Cancer Research 2016 cited by 224

  19. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

    Authors: Pedram Razavi, Maura N. Dickler, Payal D. Shah, Weiyi Toy, David N. Brown, Helen Won, Bob T. Li, Ronglai Shen, Neil Vasan, Shanu Modi, Komal Jhaveri, Betty Ann Caravella, Sujata Patil, Pier Selenica, Stephen Zamora, Aimee Cowan, Elizabeth Comen, Andy Singh, Anne M. Covey, Michael F. Berger, Clifford A. Hudis, Larry Norton, Rebecca J. Nagy, Justin I. Odegaard, Richard B. Lanman, David B. Solit, Mark E. Robson, Mario E. Lacouture, Edi Brogi, Jorge S. Reis‐Filho, Mary Ellen Moynahan, Maurizio Scaltriti, Sarat Chandarlapaty - Nature Cancer 2020 cited by 162

  20. PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition

    Authors: Pau Castel, Haley Ellis, Ružica Bago, Eneda Toska, Pedram Razavi, F. Javier Carmona, Srinivasaraghavan Kannan, Chandra Verma, Maura N. Dickler, Sarat Chandarlapaty, Edi Brogi, Dario R. Alessi, José Baselga, Maurizio Scaltriti - Cancer Cell 2016 cited by 230

  21. Validation of a digital pathology system including remote review during the COVID-19 pandemic

    Authors: Matthew G. Hanna, Victor E. Reuter, Orly Ardon, David Kim, S. Joseph Sirintrapun, Peter J. Schüffler, Klaus J. Busam, Jennifer L. Sauter, Edi Brogi, Lee K. Tan, Bin Xu, Tejus Bale, Narasimhan P. Agaram, Laura H. Tang, Lora H. Ellenson, John Philip, Lorraine Corsale, Evangelos Stamelos, Maria A. Friedlander, Peter Ntiamoah, Marc Labasin, Christine England, David S. Klimstra, Meera Hameed - Modern Pathology 2020 cited by 182

  22. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Authors: Paula I. González-Ericsson, Elisabeth Specht Stovgaard, Luz F. Sua, Emily Reisenbichler, Zuzana Kos, Jodi M. Carter, Stefan Michiels, John Le Quesne, Torsten O. Nielsen, Anne‐Vibeke Lænkholm, Stephen B. Fox, Julien Adam, John MS Bartlett, David L. Rimm, Cecily Quinn, Dieter Peeters, Maria Vittoria Dieci, Anne Vincent‐Salomon, Ian A. Cree, Akira I. Hida, Justin M. Balko, Harry R. Haynes, Isabel Frahm, Gabriela Acosta‐Haab, Marcelo Luiz Balancin, Enrique Bellolio, Wentao Yang, Pawan Kirtani, Tomoharu Sugie, Anna Ehinger, Carlos Castaneda, Marleen Kok, Heather L. McArthur, Kalliopi P. Siziopikou, Sunil Badve, Susan Fineberg, Allen M. Gown, Giuseppe Viale, Stuart J. Schnitt, Giancarlo Pruneri, Frederique Penault‐Llorca, Stephen M. Hewitt, E. Aubrey Thompson, Kimberly H. Allison, W. Fraser Symmans, Andrew M. Bellizzi, Edi Brogi, David A. Moore, Denis Larsimont, Deborah Dillon, Alexander J. Lazar, Huang‐Chun Lien, Matthew P. Goetz, Glenn Broeckx, Khalid El Bairi, Nadia Harbeck, Ashley Cimino‐Mathews, Christos Sotiriou, Sylvia Adams, S Liu, Sibylle Loibl, I‐Chun Chen, Sunil R. Lakhani, Jonathan Juco, Carsten Denkert, Elizabeth F. Blackley, Sandra Demaria, Roberto A. Leon‐Ferre, Oleg Gluz, Dimitrios Zardavas, Kenneth Emancipator, Scott Ely, Sherene Loi, Roberto Salgado, Melinda E. Sanders, International Immuno‐Oncology Biomarker Working Group - The Journal of Pathology 2020 cited by 226

  23. Phyllodes tumours of the breast: a consensus review

    Authors: Benjamin Y. Tan, Géza Ács, Sophia K. Apple, Sunil Badve, Ira J. Bleiweiss, Edi Brogi, José Palacios Calvo, David J. Dabbs, Ian O. Ellis, Vincenzo Eusebi, Gelareh Farshid, Stephen B. Fox, Shu Ichihara, Sunil R. Lakhani, Emad A. Rakha, Jorge S. Reis‐Filho, Andrea L. Richardson, Ayşegül Şahin, Fernando Schmitt, Stuart J. Schnitt, Kalliopi P. Siziopikou, Fernando Augusto Soares, Gary M. Tse, Anne Vincent‐Salomon, Puay Hoon Tan - Histopathology 2015 cited by 495

  24. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy

    Authors: David B. Page, Jianda Yuan, David Redmond, Y Hanna Wen, Jeremy C. Durack, Ryan Emerson, Stephen B. Solomon, Zhiwan Dong, Phillip Wong, Christopher Comstock, Adi Diab, Janice S. Sung, Majid Maybody, Elizabeth A. Morris, Edi Brogi, Monica Morrow, Virgilio Sacchini, Olivier Elemento, Harlan Robins, Sujata Patil, James P. Allison, Jedd D. Wolchok, Clifford A. Hudis, Larry Norton, Heather L. McArthur - Cancer Immunology Research 2016 cited by 185